Showing 672 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada

Editor's pick
ViiV press release
18 December 2012
The search for an HIV prevention vaccine

Major Breakthrough in HIV Research: Swiss Vaccine Research Institute

Editor's pick
Business Wire
18 December 2012
HIV treatment for children & young people

DNDi is awarded USD 17.3 million from UNITAID to spur development and delivery of child-adapted ARVs

Editor's pick
Eurekalert Inf Dis
12 December 2012
New & experimental HIV treatments

Six Promising HIV Drugs in the Pipeline

Editor's pick
The Body Pro
11 December 2012
New & experimental HIV treatments

FDA approves prescribing information update for EDURANT® (rilpivirine)

Editor's pick
Janssen press release
11 December 2012
New & experimental HIV treatments

Crucial step in AIDS virus maturation simulated for first time

Editor's pick
Science Daily
5 December 2012
The search for an HIV prevention vaccine

THERAVECTYS is granted authorization from the French and Belgian regulatory agencies to launch a Phase III clinical trial for its anti-HIV therapeutic vaccine candidate

Editor's pick
EATG
4 December 2012
People with limited treatment options

Redefining Expanded Access Programs for patients with MDR-HIV

Editor's pick
GMHC Treatment Issues
4 December 2012
New & experimental HIV treatments

Merck & Co and Gilead highlight new data at international HIV meeting

Editor's pick
The Pharma Letter
16 November 2012
New & experimental HIV treatments

Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients

Editor's pick
Bloomberg
14 November 2012
New & experimental HIV treatments

FDA approves new 800mg PREZISTA® (darunavir) tablet

Editor's pick
Janssen press release
12 November 2012
New & experimental HIV treatments

Is protease inhibitor monotherapy sufficient to keep HIV under control in the brain?

Editor's pick
CATIE
2 November 2012
New & experimental HIV treatments

Gilead: HIV drug meets key Phase 2 trial objective

Editor's pick
Gilead press release
31 October 2012
How HIV works

Groundbreaking Research Discovers Possible New Way To Fight HIV

Editor's pick
Medical News Today
25 October 2012
New & experimental HIV treatments

Invisible RNAs as Anti-HIV Drug Targets

Editor's pick
Genetic Engineering News
10 October 2012
Starting treatment

Thalidomide for HIV-Related IRIS Shows Promise

Editor's pick
AIDSMeds
24 September 2012
New & experimental HIV treatments

Stribild (a.k.a. "Quad") Performs Well for People Over 50, Study Finds

Editor's pick
The Body
24 September 2012
Health services & systems

South Africa to open US$8 million HIV, TB facility

Editor's pick
SciDevNet
21 September 2012
New & experimental HIV treatments

Avexa’s HIV integrase inhibitors show activity against drug-resistant HIV with potential for once-daily dosing

Editor's pick
Avexa press release
20 September 2012
Treatment guidelines

Stribild Receives ‘Alternative’ U.S. Guidelines Ranking

Editor's pick
AIDSMeds
19 September 2012
New & experimental HIV treatments

HIV Drug Consortium Wins €4M EU Funding

Editor's pick
Genetic Engineering News
18 September 2012
Pharmaceutical industry

Gilead's HIV pill could be market leader in 3-5 years: JP Morgan

Editor's pick
CNBC
18 September 2012
New & experimental HIV treatments

New HIV Drugs Promising but Unworkable

Editor's pick
MedPage Today
14 September 2012
New & experimental HIV treatments

Long-Lasting HIV Drug Could Change Therapy

Editor's pick
MedPage Today
13 September 2012